Kainate-evoked changes in dystrophin messenger RNA levels in the rat hippocampus

Neuroscience

Volumn 84, Issue 2, 1998, Pages 467-477

  Gorecki D C ^a   Lukasiuk K ^a   Szklarczyk, A ^b   Kaczmarek, L ^b  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

Author keywords

Dystroglycan; Dystrophin; Kainate; Pentylenetetrazole

Indexed keywords

DYSTROGLYCAN; DYSTROPHIN; GLUTAMATE RECEPTOR; KAINIC ACID; MESSENGER RNA; PENTETRAZOLE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENTATE GYRUS; GENE; HIPPOCAMPUS; IN SITU HYBRIDIZATION; MALE; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SYNAPTIC MEMBRANE;

ANIMALS; BASE SEQUENCE; CYTOSKELETAL PROTEINS; DNA PROBES; DYSTROGLYCANS; DYSTROPHIN; GENE EXPRESSION REGULATION; HIPPOCAMPUS; IN SITU HYBRIDIZATION; KAINIC ACID; KINETICS; MALE; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; NEURONS; RATS; RATS, WISTAR; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 0345515991     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(97)00562-9     Document Type: Article

References (44)

1. Ben-Ari Y. Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience. 14:1985;375-403.
2. Biral D., Senter L., Salviati G. Increased expression of dystrophin, beta-dystroglycan and adhalin in denervated rat muscles. J. Muscle Res. Cell Motil. 17:1996;523-532.
3. Bliss T. V., Collingridge G. L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature. 361:1993;31-39.
4. Brenman J. E., Chao D. S., Gee S. H., McGee A. W., Craven S. E., Santillano D. R., Wu Z., Huang F., Xia H., Peters M. F., Froehner S. C., Bredt D. S. Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and α1-syntrophin mediated by PDZ domains. Cell. 84:1996;757-767.
5. Burns M. E., Augustine G. J. Synaptic structure and function: dynamic organization yields architectural precision. Cell. 83:1995;187-194.
6. Chang W. J., Iannaccone S. T., Lau K. S., Masters B. S., McCabe T. J., McMillan K., Padre R. C., Spencer M. J., Tidball J. G., Stull J. T. Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy. Proc. natn. Acad. Sci. U.S.A. 93:1996;9142-9147.
7. Cowen T., Thrasivoulou C. A microscopical assay using a densitometric application of image analysis to quantify neurotransmitter dynamics. J. Neurosci. Meth. 45:1992;107-116.
8. Elmer E., Alm P., Kokaia Z., Kokaia M., Larsson B., Keep M., Andersson K.-E., Lindvall O. Regulation of neuronal nitric oxide synthase mRNA levels in rat brain by seizure activity. NeuroReport. 7:1996;1335-1339.
9. Emery A. E. H. (1993) Duchenne Muscular Dystrophy, 2nd edn, pp. 115-120. Oxford University Press, Oxford.
10. Filipkowski R. K., Hetman M., Kaminska B., Kaczmarek L. DNA fragmentation in rat brain after intraperitoneal administration of kainate. NeuroReport. 5:1994;1538-1540.
11. Garrity P. A., Zipursky S. L. Neuronal target recognition. Cell. 83:1995;177-185.
12. Gazzaley A. H., Benson D. L., Huntley G. W., Morrison J. H. Differential subcellular regulation of NMDAR1 protein and mRNA in dendrites of dentate gyrus granule cells after perforant path transection. J. Neurosci. 17:1997;2006-2017.
13. Górecki D. C., Abdulrazzak H., Łukasiuk K., Barnard E. A. Differential expression of syntrophins and analysis of alternatively spliced dystrophin transcripts in the mouse brain. Eur. J. Neurosci. 9:1997;965-976.
14. Górecki D. C., Barnard E. A. Specific expression of G-dystrophin (Dp71) in the brain. NeuroReport. 6:1995;893-896.
15. Górecki D. C. and Barnard E. A. (1997) Expression of the dystrophin complex in the brain. In Dystrophin: Gene, Protein and Function (eds Brown S. and Lucy J.), pp. 105-138. Cambridge University Press, Cambridge.
16. Górecki D. C., Derry J. M. J., Barnard E. Dystroglycan: brain localisation and chromosome mapping in the mouse. Hum. molec. Genet. 3:1994;1589-1597.
17. Górecki D. C., Monaco A. P., Derry J. M. J., Walker A. P., Barnard E. A., Barnard P. J. Expression of four alternative dystrophin transcripts in brain regions regulated by different promoters. Hum. molec. Genet. 1:1992;505-510.
18. Greenberg D. S., Schatz Y., Levy Z., Pizzo P., Yaffe D., Nudel U. Reduced levels of dystrophin associated proteins in the brain of mice deficient for Dp71. Hum. molec. Genet. 5:1996;1299-1303.
19. Hetman M., Filipkowski R. K., Domagala W., Kaczmarek L. Elevated cathepsin D expression in kainate-evoked rat brain neurodegeneration. Expl Neurol. 136:1995;53-63.
20. Ibraghimov-Beskrovnaya O., Ervasti J. M., Leveille C. J., Slaughter C. A., Sernett S. W., Campbell K. P. Primary structure of dystrophin-associated glycoprotein linking dystrophin to the extracellular matrix. Nature. 355:1992;696-702.
21. Ibraghimov-Beskrovnaya O., Milatovich A., Ozcelik T., Yang B., Koepnick K., Francke U., Campbell K. P. Human dystroglycan: skeletal muscle cDNA, genomic structure, origin of tissue specific isoforms and chromosomal localisation. Hum. molec. Genet. 2:1993;1651-1657.
22. Jung D., Filliol D., Metz-Boutigue M.-H., Rendon A. Characterization and subcellular localization of the dystrophin-protein 71 (Dp71) from brain. Neuromusc. Disord. 3:1993;515-518.
23. Kaminska B., Filipkowski R. K., Zurkowska G., Lason W., Przewlocki R., Kaczmarek L. Dynamic changes in composition of AP1 transcription factor DNA binding activity in rat brain following kainate induced seizures and cell death. Eur. J. Neurosci. 6:1994;1558-1566.
24. Kim T.-W., Xu J.-L., Black I. B. Detection of dystrophin in the postsynaptic density of rat brain and deficiency in mouse model of Duchenne muscular dystrophy. Proc. natn. Acad. Sci. U.S.A. 89:1992;11642-11644.
25. Konopka D., Nowicka D., Filipkowski R. K., Kaczmarek L. Kainate-evoked secondary gene expression in the rat hippocampus. Neurosci. Lett. 185:1995;167-170.
26. Lambert M., Chafey P., Hugnot J. P., Koulakoff A., Berwald-Netter Y., Billard C., Morris G. E., Kahn A., Kaplan J. C., Gilgenkrantz H. Expression of the transcripts initiated in the 62nd intron of the dystrophin gene. Neuromusc. Disord. 3:1993;519-524.
27. Lederfein D., Yaffe D., Nudel U. A housekeeping type promoter, located in the 3′ region of the Duchenne muscular dystrophy gene, controls the expression of Dp71, a major product of the gene. Hum. molec. Genet. 2:1993;1883-1888.
28. Lidov H. G. W., Byers T. J., Watkins S. C., Kunkel L. M. Localisation of dystrophin to postsynaptic regions of central nervous system cortical neurons. Nature. 348:1990;725-728.
29. Łukasiuk K., Kaczmarek L. AP-1 and CRE DNA binding activities in rat brain following pentylenetetrazole induced seizures. Brain Res. 643:1994;227-233.
30. Montanaro F., Carbonetto S., Campbell K. P., Lindenbaum M. Dystroglycan expression in the wild type and mdx mouse neural retina: synaptic colocalization with dystrophin, DRP but not laminin. J. Neurosci. Res. 42:1995;528-538.
31. Nedivi E., Fieldust S., Theill L. E., Hevroni D. A set of genes expressed in response to light in the adult cerebral cortex and regulated during development. Proc. natn. Acad. Sci. U.S.A. 93:1996;2048-2053.
32. Nedivi E., Hevroni D., Naot D., Israeli D., Citri Y. Numerous candidate plasticity-related genes revealed by differential cDNA cloning. Nature. 363:1993;718-722.
33. Olink-Coux M., Hollenbeck P. J. Localization and active transport of mRNA in axons of sympathetic neurons in culture. J. Neurosci. 16:1996;1346-1358.
34. Pollard H., Cantagrel S., Charriaut-Marlangue C., Moreau J., Ben-Ari Y. Apoptosis associated DNA fragmentation in epileptic brain damage. NeuroReport. 5:1994;1053-1055.
35. Pollard H., Charriaut-Marlangue C., Cantagrel S., Represa A., Rabin Moreau J., Ben-Ari Y. Kainate induced apoptotic cell death in hippocampal neurons. Neuroscience. 63:1994;7-18.
36. Repressa A., Tremblay E., Ben-Ari Y. Sprouting of mossy fibers in the hippocampus of epileptic human and rat. Adv. exp. Med. Biol. 268:1990;419-424.
37. Schofield J. N., Górecki D. C., Blake D. J., Davies K. E., Edwards Y. H. Dystroglycan mRNA expression during normal and mdx mouse embryogenesis; a comparison with utrophin and the apodystrophins. Devl Dynamics. 204:1995;178-185.
38. Schwob J. E., Fuller T., Price J. L., Olney J. W. Widespread patterns of neuronal damage following systemic or intracerebral injections of kainic acid: a histological study. Neuroscience. 5:1980;991-1014.
39. Smalheiser N. R., Kim E. Purification of cranin, a laminin binding membrane protein. J. biol. Chem. 270:1995;15425-15433.
40. Sperk G. Kainic acid seizures in the rat. Prog. Neurobiol. 42:1994;1-32.
41. Sperk G., Lassmann H., Baran H., Kish S. J., Seitelberger F., Hornykiewicz O. Kainic acid induced seizures: neurochemical and histopathological changes. Neuroscience. 10:1983;1301-1315.
42. Tennyson C. N., Dally G. Y., Ray P. N., Worton R. G. Expression of the dystrophin isoform Dp71 in differentiating human fetal myogenic cultures. Hum. molec. Genet. 5:1996;1559-1566.
43. Van Minnen J. RNA in the axonal domain: a new dimension in neuronal functioning? Histochem. J. 26:1994;377-391.
44. Wickens M., Anderson P., Jackson R. J. Life and death in the cytoplasm: messages from the 3′ end. Curr. Opin. Genet. Dev. 7:1997;220-232.